Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment September 26, 2019 Disclosures: TBA
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: The Medically Ill Patients in AUGUSTUS September 26, 2019 Disclosures: TBA
Dr. Michael J. Mack and Dr. C. Michael Gibson Discuss: COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation September 26, 2019 Disclosures: TBA
Dr. Kenneth Ouriel and Dr. C. Michael Gibson Discuss: LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease September 26, 2019 Disclosures: TBA
Dr. Samir Kapadia, Dr. Horst Sievert and Dr. C. Michael Gibson Discuss: Results of REDUCE-FMR September 26, 2019 Disclosures: TBA
Dr. Carlo Briguori and Dr. C. Michael Gibson Discuss: REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy September 26, 2019 Disclosures: TBA
Dr. Steven Goldberg, Chief Clinical Officer, Cardiac Dimensions and Dr. C. Michael Gibson Discuss: The CARILLON Device September 26, 2019 Disclosures: TBA
Dr. Jonas Lanz and Dr. C. Michael Gibson Discuss: SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis September 26, 2019 Disclosures: TBA
Dr. Mayra Guerrero and Dr. C. Michael Gibson Discuss: Mitral Valve-in-Valve: 1-Year Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprotheses September 26, 2019 Disclosures: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2019 Daily Wrap-Up – September 26, 2019 September 26, 2019 Disclosures: TBA
